Chronic Physiological Hypoxia and High Glucose Concentration Promote Resistance of T98G Glioblastoma Cell Line to Temozolomide

Drug Designing: Open Access
doi 10.4172/2169-0138.1000117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

YKL-40 Downregulation Is a Key Factor to Overcome Temozolomide Resistance in a Glioblastoma Cell Line

Oncology Reports
MedicineCancer ResearchOncology
2014English

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Neurologia Medico-Chirurgica
SurgeryNeurology
2018English

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

PLoS ONE
Multidisciplinary
2015English

Metformin and Temozolomide, a Synergic Option to Overcome Resistance in Glioblastoma Multiforme Models

Oncotarget
Oncology
2017English

Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

18f-Fet and 18f-FCH Uptake in Human Glioblastoma T98G Cell Lines

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

DNA-methylation-mediated Activating of lncRNA SNHG12 Promotes Temozolomide Resistance in Glioblastoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2020English

A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

RRAD Promotes EGFR-Mediated STAT3 Activation and Induces Temozolomide Resistance of Malignant Glioblastoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy